BioCentury
ARTICLE | Clinical News

Centaur completes CPI-1189 enrollment

April 25, 2000 7:00 AM UTC

Centaur (Sunnyvale, Calif.) completed enrollment of 64 HIV patients with cognitive and motor impairment in a placebo-controlled Phase IIa study of CPI-1189 nitrone-related therapeutic to treat AIDS de...